We use own and third-party cookies to measure the website’s activity with the purpose of implementing improvements based on analysing the data on how users use the service.
ACCEPT
REJECT

Inside TAB Healthcare

And the Nobel goes to…
October 05, 2018

James P. Allison and Tasuku Honjo “for their discovery of cancer therapy by inhibition of negative immune regulation”. This year the Nobel Prize in Medicine has been awarded to the fathers of immunotherapy. Immunotherapy is a type of treatment that stimulates the body’s natural defenses to fight cancer, thus stopping or delaying the growth of cancer cells and preventing the tumour from spreading to other parts of the body.

As the Swedish institute that awards the Nobel Prize states, immunotherapy “has been a revolution in cancer therapy and has changed our vision of this disease forever “. Thanks to immunotherapy, effective treatments have been developed for lung, kidney and skin cancer. TAB Healthcare have been involved in many market research projects on targeted therapies, including monoclonal antibodies and immunotherapy. None of them would have been possible without the visionary work of researchers like Allison and Honjo. Congratulations & Omedetou Gozaimasu!